CN105997896B - 治疗非霍奇金淋巴瘤的注射用冻干粉及其制备方法 - Google Patents
治疗非霍奇金淋巴瘤的注射用冻干粉及其制备方法 Download PDFInfo
- Publication number
- CN105997896B CN105997896B CN201610364343.5A CN201610364343A CN105997896B CN 105997896 B CN105997896 B CN 105997896B CN 201610364343 A CN201610364343 A CN 201610364343A CN 105997896 B CN105997896 B CN 105997896B
- Authority
- CN
- China
- Prior art keywords
- freeze
- injection
- temperature
- dried powder
- lactose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610364343.5A CN105997896B (zh) | 2016-05-28 | 2016-05-28 | 治疗非霍奇金淋巴瘤的注射用冻干粉及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610364343.5A CN105997896B (zh) | 2016-05-28 | 2016-05-28 | 治疗非霍奇金淋巴瘤的注射用冻干粉及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105997896A CN105997896A (zh) | 2016-10-12 |
CN105997896B true CN105997896B (zh) | 2019-07-05 |
Family
ID=57091252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610364343.5A Active CN105997896B (zh) | 2016-05-28 | 2016-05-28 | 治疗非霍奇金淋巴瘤的注射用冻干粉及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105997896B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1382039A (zh) * | 1999-10-22 | 2002-11-27 | 诺威斯药物有限公司 | 6,9-二-[(2-氨基乙基)氨基]苯并[g]异喹啉-5,10-二酮二马来酸酯的脂质体制剂 |
WO2003097101A1 (en) * | 2002-05-16 | 2003-11-27 | Cell Therapeutics Europe S.R.L. | Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
CN103479578A (zh) * | 2012-06-14 | 2014-01-01 | 沈阳药科大学 | 一种马来酸匹杉琼的脂质体制剂及其制备工艺 |
CN105596295A (zh) * | 2016-01-25 | 2016-05-25 | 北京博恩特药业有限公司 | 马来酸匹杉琼脂质体及其制备方法 |
-
2016
- 2016-05-28 CN CN201610364343.5A patent/CN105997896B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1382039A (zh) * | 1999-10-22 | 2002-11-27 | 诺威斯药物有限公司 | 6,9-二-[(2-氨基乙基)氨基]苯并[g]异喹啉-5,10-二酮二马来酸酯的脂质体制剂 |
WO2003097101A1 (en) * | 2002-05-16 | 2003-11-27 | Cell Therapeutics Europe S.R.L. | Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
CN103479578A (zh) * | 2012-06-14 | 2014-01-01 | 沈阳药科大学 | 一种马来酸匹杉琼的脂质体制剂及其制备工艺 |
CN105596295A (zh) * | 2016-01-25 | 2016-05-25 | 北京博恩特药业有限公司 | 马来酸匹杉琼脂质体及其制备方法 |
Non-Patent Citations (3)
Title |
---|
Pixantrone (BBR2778): a new immunosuppressant in multiple sclerosis with a low cardiotoxicity;R.E. Gonsette;《Journal of the Neurological Sciences》;20040608;第223卷;第81-86页 |
Pixantrone dimaleate for treating non-Hodgkin’s lymphoma;Pettengell et al.;《Expert Opinion on Orphan Drugs》;20150630;第3卷(第6期);第747-757页 |
Preparation of Pixantrone/Poly(g-glutamic acid) Nanoparticles through Complex Self-Assembly for Oral Chemotherapy;Lili Meng et al.;《MACROMOLECULAR BIOSCIENCE》;20121130;第12卷(第11期);第1524-1533页 |
Also Published As
Publication number | Publication date |
---|---|
CN105997896A (zh) | 2016-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102302525B (zh) | 一种银杏叶组合物及其制备方法 | |
US11351184B2 (en) | Preparation of Pulsatilla saponin B4 for injection | |
CN105434373B (zh) | 一种注射用奥拉西坦冻干制剂及其制备方法 | |
US7163704B2 (en) | Injection made from Ixeris Sonchifolia Hance for treatment of cardio-cerebral vascular diseases and fundus diseases and method of producing thereof | |
CN105859903A (zh) | 一种北沙参多糖及其制备方法和应用 | |
CN101711746B (zh) | 一种注射用更昔洛韦冻干制剂及其制备方法 | |
CN102113994A (zh) | 一种脑血管扩张药及其制备方法 | |
CN105997896B (zh) | 治疗非霍奇金淋巴瘤的注射用冻干粉及其制备方法 | |
CN107625729A (zh) | 泊沙康唑口服混悬液及其制备方法 | |
CN105079015B (zh) | 曲克芦丁冻干粉针剂及其制备方法 | |
CN104825402B (zh) | 一种含有吉西他滨的注射用药物组合物 | |
CN106109401A (zh) | 一种高纯度氨甲环酸注射剂及其制备方法以及在心脏外科手术体外循环围术期适应症的应用 | |
CN103845295A (zh) | 一种注射用帕洛诺司琼制剂及其制备方法 | |
CN114748425A (zh) | 一种人参皂苷Rb1脂质体及其制备方法 | |
CN105769776B (zh) | 一种治疗非霍奇金淋巴瘤的冻干组合物及其制备方法 | |
CN107157941A (zh) | 一种达沙替尼纳米制剂及其制备方法 | |
CN108969548A (zh) | 白簕叶总多酚的用途 | |
CN105769757B (zh) | 一种治疗非霍奇金淋巴瘤的注射液及其制备方法 | |
CN101376022B (zh) | 含聚乙二醇降纤酶的药物组合物 | |
CN110664741B (zh) | 提高荷叶碱生物利用度的荷叶碱溶液的制备方法 | |
CN110037987B (zh) | 一种枸橼酸他莫昔芬脂质体及其制备方法 | |
CN101224228B (zh) | 一种三七总皂苷冻干粉针剂及其制备方法 | |
CN106643005A (zh) | 叔丁醇在三七总皂苷或其组合物冷冻干燥过程中的应用 | |
CN114177147A (zh) | 一种注射用特利加压素的制备方法以及制得的注射用特利加压素 | |
CN113100370A (zh) | 一种蓝盆花功能性饮料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180604 Address after: 410015 Room 303, No. 3, Xinggong science and Technology Park, No. 100 Lu Yun Road, Changsha hi tech Development Zone, Hunan, China. Applicant after: Changsha is as small as the Mdt InfoTech Ltd Address before: 410015 No. 102, Bront District, Hester moonlight estate, 118 Zheng Xing Road, Lei Feng Town, Changsha high tech Development Zone, Changsha, Hunan, China. Applicant before: HUNAN XIXIN INFORMATION TECHNOLOGY CO., LTD. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190522 Address after: 410205 Room 801, Lugu Avenue 636 Luyuan, Changsha High-tech Development Zone, Changsha City, Hunan Province Applicant after: CHANGSHA QIUDIANBING INFORMATION SCIENCE & TECHNOLOGY CO., LTD. Address before: 410015 Room 303, No. 3, Xinggong science and Technology Park, No. 100 Lu Yun Road, Changsha hi tech Development Zone, Hunan, China. Applicant before: Changsha is as small as the Mdt InfoTech Ltd |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191017 Address after: 200120 No. 1150, Guiqiao Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai Patentee after: Shanghai Lizhu Pharmaceutical Co., ltd. Address before: 410205 Room 801, Lugu Avenue 636 Luyuan, Changsha High-tech Development Zone, Changsha City, Hunan Province Patentee before: CHANGSHA QIUDIANBING INFORMATION SCIENCE & TECHNOLOGY CO., LTD. |
|
TR01 | Transfer of patent right |